164 related articles for article (PubMed ID: 30737134)
1. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
[TBL] [Abstract][Full Text] [Related]
2. Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
Cao J; Ma C; Zang J; Gao S; Gao Q; Kong X; Yan Y; Liang X; Ding Q; Zhao C; Wang B; Xu W; Zhang Y
Bioorg Med Chem; 2018 Jul; 26(12):3145-3157. PubMed ID: 29859750
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.
Su L; Jia Y; Zhang L; Xu Y; Fang H; Xu W
Bioorg Med Chem; 2012 Jun; 20(12):3807-15. PubMed ID: 22607877
[TBL] [Abstract][Full Text] [Related]
4. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Ma C; Jin K; Cao J; Zhang L; Li X; Xu W
Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.
Su L; Fang H; Yang K; Xu Y; Xu W
Bioorg Med Chem; 2011 Jan; 19(2):900-6. PubMed ID: 21194957
[TBL] [Abstract][Full Text] [Related]
6. Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Ma C; Cao J; Liang X; Huang Y; Wu P; Li Y; Xu W; Zhang Y
Eur J Med Chem; 2016 Jan; 108():21-27. PubMed ID: 26629857
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.
Zhang X; Zhang L; Zhang J; Feng J; Yuan Y; Fang H; Xu W
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):545-51. PubMed ID: 22380779
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors.
Yang K; Fen J; Fang H; Zhang L; Gong J; Xu W
J Enzyme Inhib Med Chem; 2012 Apr; 27(2):302-10. PubMed ID: 21770859
[TBL] [Abstract][Full Text] [Related]
9. LYP3, a new bestatin derivative for aminopeptidase N inhibition.
Luan Y; Ma C; Sui Z; Wang X; Feng J; Liu N; Jing F; Wang Y; Li M; Fang H; Xu W
Med Chem; 2011 Jan; 7(1):32-6. PubMed ID: 21235517
[TBL] [Abstract][Full Text] [Related]
10. A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells.
Saitoh Y; Koizumi K; Minami T; Sekine K; Sakurai H; Saiki I
Biol Pharm Bull; 2006 Apr; 29(4):709-12. PubMed ID: 16595904
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
[TBL] [Abstract][Full Text] [Related]
12. The effect of different species aminopeptidase N structure on the activity screening of aminopeptidase N inhibitor.
Wang X; Zhang L; Yang K; Zhang C; Zhang J; Fang H; Xu W
Biol Pharm Bull; 2010; 33(10):1658-65. PubMed ID: 20930372
[TBL] [Abstract][Full Text] [Related]
13. Novel small molecule nonpeptide aminopeptidase n inhibitors with a cyclic imide skeleton.
Shimazawa R; Takayama H; Fujimoto Y; Komoda M; Dodo K; Yamasaki R; Shirai R; Koiso Y; Miyata K; Kato F; Kato M; Miyachi H; Hashimoto Y
J Enzyme Inhib; 1999; 14(4):259-75. PubMed ID: 10445048
[TBL] [Abstract][Full Text] [Related]
14. Development of Hydroxamate Derivatives Containing a Pyrazoline Moiety as APN Inhibitors to Overcome Angiogenesis.
Liu Y; Zhao D; Zhang C; Fang H; Shen Q; Wang Z; Cao J
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500432
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.
Pan H; Yang K; Zhang J; Xu Y; Jiang Y; Yuan Y; Zhang X; Xu W
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):717-26. PubMed ID: 22545941
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Pyrazoline-Based Hydroxamic Acid Derivatives as Aminopeptidase N (APN) Inhibitors.
Cao J; Zang J; Ma C; Li X; Hou J; Li J; Huang Y; Xu W; Wang B; Zhang Y
ChemMedChem; 2018 Mar; 13(5):431-436. PubMed ID: 29377564
[TBL] [Abstract][Full Text] [Related]
17. Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.
Amin SA; Adhikari N; Jha T
J Med Chem; 2018 Aug; 61(15):6468-6490. PubMed ID: 29630364
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors.
Yang K; Wang Q; Su L; Fang H; Wang X; Gong J; Wang B; Xu W
Bioorg Med Chem; 2009 Jun; 17(11):3810-7. PubMed ID: 19423354
[TBL] [Abstract][Full Text] [Related]
19. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
Imamura N; Kimura A
Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
[TBL] [Abstract][Full Text] [Related]
20. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin.
Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Park HJ; Shim BS; Choi SH; Kwon HJ
Chem Biol; 2003 Aug; 10(8):695-704. PubMed ID: 12954328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
